Crossref
Status Report on HIV Drug Treatment Transition from Tenofovir/Lamivudine/Efavirenz (TLE 600mg) to Tenofovir/Lamivudine/Dolutegravir (TLD) in Malawi
Public Health Open Access · 2018
DOI: 10.23880/phoa-16000118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health Open Access, 2018. Verfasst von Babaye Y.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Y, B. (2018). Status Report on HIV Drug Treatment Transition from Tenofovir/Lamivudine/Efavirenz (TLE 600mg) to Tenofovir/Lamivudine/Dolutegravir (TLD) in Malawi. Public Health Open Access. https://doi.org/10.23880/phoa-16000118
Vancouver
Y B. Status Report on HIV Drug Treatment Transition from Tenofovir/Lamivudine/Efavirenz (TLE 600mg) to Tenofovir/Lamivudine/Dolutegravir (TLD) in Malawi. Public Health Open Access. 2018. doi:10.23880/phoa-16000118
BibTeX
@article{Y2018,
author = {Y, Babaye},
title = {Status Report on HIV Drug Treatment Transition from Tenofovir/Lamivudine/Efavirenz (TLE 600mg) to Tenofovir/Lamivudine/Dolutegravir (TLD) in Malawi},
journal = {Public Health Open Access},
year = {2018},
doi = {10.23880/phoa-16000118}
}
EUVIMED